logo
Is Deion Sanders leaving Colorado Buffaloes? Coach Prime to address health concerns in upcoming press conference

Is Deion Sanders leaving Colorado Buffaloes? Coach Prime to address health concerns in upcoming press conference

Time of India3 days ago
Deion Sanders might leave Colorado (Image via Getty Images)
Deion Sanders
' offseason has been a little unusual this year because the third-year head coach of the Colorado Buffaloes was recovering from an undisclosed health condition at his Texas home during the summer.
After weeks of speculation over his future, he will now meet the media in a much-awaited press conference on Monday at 11 a.m. Mountain Time to provide updates about his health. He will be accompanied by members of his medical team and representatives from CU Anschutz and UCHealth.
Deion Sanders
set to reveal health battle details and address Colorado exit rumors in press conference
Deion Sanders is prepared to discuss his most recent health issue during a news conference on Monday after keeping quiet about it for a long time.
His medical team will also join him to discuss the issues.
Persistent rumors that he is leaving the
Colorado Buffaloes
because of his health issues gave rise to uncertainty. The only available information about the coach's health condition is that he shed 14 pounds. However, today's event will correct the record, according to his long-time confidant, "Uncle Neely."
Uncle Neely, who has had a tight relationship with the coach during his coaching career, gave a sneak peek at what he might say to the media. He said:
'It was one of those no-camera team meetings so that Coach Prime could talk to the team… He's probably put something out on his Instagram, a clip from Bucky [Deion Sanders Jr.].
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Is it better to shower in the morning or at night? Here's what a microbiologist says
CNA
Read More
Undo
He continued:
"So tomorrow's press conference, it's just going to be one of those things where a lot of the naysayers and player haters are really going to get to know what's been going on for the past 60 to 90 days with Coach Prime and what he fought through and overcame."
Deion Sanders is physically not well (Image Via Getty Images)
Deion Sanders has remained rather quiet this offseason despite enduring severe health problems in previous years. He further went through multiple surgeries and the partial amputation of two toes.
His lack of participation in summer activities only fueled rumors that his time at Colorado Buffaloes was running out.
Understanding the gravity of the situation, his son once said in an emotional video:
"Yesterday was tough... because I had to make a will.
Fans and experts have been waiting for an explanation ever since. Although Deion Sanders has started sharing videos that show he's reportedly "back and feeling great," it's still unclear what exactly his issues are. Now, everyone is eagerly waiting for some answers.
Also read:
Jonathan Kuminga draws sign-and-trade interest from Phoenix Suns and Sacramento Kings, delays Golden State Warriors deal
Catch Rani Rampal's inspiring story on Game On, Episode 4. Watch Here!
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Justin Timberlake, Avril Lavigne, Justin Bieber and more: Celebs who have opened up about their Lyme disease battles
Justin Timberlake, Avril Lavigne, Justin Bieber and more: Celebs who have opened up about their Lyme disease battles

Hindustan Times

time22 minutes ago

  • Hindustan Times

Justin Timberlake, Avril Lavigne, Justin Bieber and more: Celebs who have opened up about their Lyme disease battles

Justin Timberlake shocked his fans with the revelation that he has been battling Lyme disease, describing it as a 'relentlessly debilitating' condition in a candid Instagram post. The announcement comes after the singer faced intense backlash over recent world tour performances, with some fans criticizing him for appearing 'lazy' and 'tired' on stage, as reported by The Sun. Justin Timberlake disclosed his struggle with Lyme disease after facing backlash for his tour performances. (Carsten Koall/dpa via AP)(AP) Also Read: Justin Timberlake Lyme disease: Singer opens up on health struggles; fans ask, 'Is there a cure?' What is Lyme disease? According to the EDS Clinic, Lyme disease is a bacterial infection transmitted through the bite of an infected tick. It often begins with flu-like symptoms and may include fatigue, joint pain, and a distinctive 'bullseye' rash around the bite site. If detected at an early stage, it can be cured with the help of antibiotics. Delaying treatment for Lyme disease can lead to debilitating symptoms, including nerve damage and heart rhythm disturbances. For some people, the symptoms of Lyme disease persist for months after they are diagnosed with infection. This condition is known as long Lyme Chronic lyme disease. Symptoms of this include severe fatigue, joint and muscle pain, and cognitive issues. Also Read: Hulk Hogan cause of death: What is acute myocardial infarction and leukemia's role? Other celebs diagnosed with Lyme disease Many celebrities have been diagnosed with it and have shared their journey in public to raise awareness about the often misunderstood disease. Following is the list of celebrities who have been vocal about their Lyme disease. Avril Lavigne Justin Bieber Yolanda Hadid Bella Hadid Ben Stiller Shania Twain Alec Baldwin Amy Schumer Kelly Osbourne Ramona Singer Fletcher Debbie Gibson Ryan Sutter Kelley Flanagan Riley Keough Ally Hilfiger Miranda Hart Kris Kristofferson ‍

Justin Timberlake Lyme disease: Singer opens up on health struggles; fans ask, ‘Is there a cure?'
Justin Timberlake Lyme disease: Singer opens up on health struggles; fans ask, ‘Is there a cure?'

Hindustan Times

time23 minutes ago

  • Hindustan Times

Justin Timberlake Lyme disease: Singer opens up on health struggles; fans ask, ‘Is there a cure?'

Justin Timberlake revealed that he has been diagnosed with Lyme disease. The singer, in a lengthy social media post, reflected on his health struggles and addressed concerns about his Forget Tomorrow tour, which wrapped up this week. Justin Timberlake performs at the 2025 BottleRock Napa Valley(AP) 'I've been battling some health issues, and was diagnosed with Lyme disease -— which I don't say so you feel bad for me –– but to shed some light on what I've been up against behind the scenes,' the 44-year-old wrote on Instagram. The pop star attached photos from his tour. "As I'm reflecting on the tour and festival tour — I want to tell you a little bit about what's going on with me.' 'If you've experienced this disease or know someone who has — then you're aware: living with this can be relentlessly debilitating, both mentally and physically. When I first got the diagnosis I was shocked for sure. But, at least I could understand why I would be onstage and in a massive amount of nerve pain or, just feeling crazy fatigue or sickness. I was faced with a personal decision. Stop touring? Or, keep going and figure it out. I decided the joy that performing brings me far outweighs the fleeting stress my body was feeling. I'm so glad I kept going," he further added. Timberlake's announcement has worried fans. One of them asked on X: 'Is there a cure for Lyme disease?' What is Lyme disease? According to the Mayo Clinic, Lyme disease is caused by borrelia bacteria, which is carried by some ticks. Symptoms include rashes, body pain and stiffness, muscle weakness and immune-system issues. Can Lyme disease be cured? As per Centers for Disease Control and Prevention (CDC), 'most cases of Lyme disease can be treated with 10-14 days of antibiotics'. 'People treated with appropriate antibiotics in the early stages of Lyme disease usually recover rapidly and completely.'

Healthcare costs in US to shoot up following Trump tariff on Indian goods: Industry experts
Healthcare costs in US to shoot up following Trump tariff on Indian goods: Industry experts

Time of India

time27 minutes ago

  • Time of India

Healthcare costs in US to shoot up following Trump tariff on Indian goods: Industry experts

New Delhi: Healthcare costs in the US will increase following the imposition of sweeping 25 per cent tariff plus an unspecified penalty on Indian goods, experts from pharmaceuticals and medical devices industry said on Thursday. President Donald Trump on Wednesday announced the imposition of a 25 per cent tariff on all goods coming from India starting August 1, plus an unspecified penalty for buying Russian crude oil and military equipment. Explore courses from Top Institutes in Please select course: Select a Course Category healthcare Project Management Finance Technology Operations Management Artificial Intelligence Data Science Management PGDM Data Science Product Management Degree Others Healthcare Public Policy Design Thinking Cybersecurity Digital Marketing others CXO Leadership MCA MBA Data Analytics Skills you'll gain: Duration: 11 Months IIM Lucknow CERT-IIML Healthcare Management India Starts on undefined Get Details Profits for Indian pharmaceutical firms may decline and research and development may stagnate. However, for the medical devices sector as long as the gap between duty on China and India is over 15- 20 per cent, there are positive prospects for exports to the US, according to experts. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Top 15 Most Beautiful Women in the World Undo "India isn't just a key supplier of generics to the US. We are a part of the backbone of affordable global healthcare. These duties may interrupt the smooth trade flow, inflate US drug costs, stall treatments, and put even greater pressure on American healthcare budgets," OmniActive Health Technologies Executive Chairman and MD Sanjaya Mariwala said. On the other hand, he said, "Back home, the profits for Indian pharmaceutical firms may decline, and R&D may stagnate, slowing down innovation and stalling new drug clearances." Live Events AiMeD (Association of Indian Medical Device Industry) Forum Coordinator Rajiv Nath said, "Duties impact for Indian medical devices sector has to be seen from relative competitiveness - as long as duty gap between Chinese versus Indian is over 15- 20 per cent, we have positive prospects to export to USA and even put production lines in USA." Currently Indonesia and Vietnam have lower duties by 6 per cent. So for products made there they will possibly enjoy a price competitive advantage over India, he added. Stating that clarity will come after August 12 as then duties on Chinese goods will be clear, Nath said, "They were increased to over 50 per cent but temporarily reduced to 30 per cent. If post-August duties on Chinese medical devices revert to over 50 per cent and on Indian at 25 per cent, the export prospects versus China are in our favour..." He further said, "Suffice to say that whatever is the final duty that is finally announced on medical devices, if it's at least 15-20 per cent lower than applicable duty rates by US onto China then there is a strong opportunity for Indian medical devices to increase their exports to US market, if they are able to absorb the excessive high cost of regulatory approval of USFDA for market entry and find that these costs to export are sustainable over the years." However, he said, the government of India and manufacturers will need to work to improve India's competitiveness "so that we can offset the 6 per cent disadvantage over Indonesian and Vietnam competitors". Grant Thornton Bharat Partner and Tax Controversy Management Leader Manoj Mishra pointed out that the strong language used by President Trump and ongoing investigations into drug imports mean that the risk is not over yet. "Indian pharma companies should stay prepared for possible changes, especially if sector-specific duties are introduced later. That said, these tariffs are likely to be in place only for a short period, as both countries are expected to fast-track discussions for a Bilateral Trade Agreement. A balanced and stable trade deal will be key to protecting long-term interests of the sector," he noted. Similarly, Choice Broking Equity Research Analyst- Pharma Sector, Maitri Sheth said the US remains heavily reliant on India for its pharmaceutical needs, with about 50 per cent of generic drugs sourced from India. "Given the critical nature of healthcare and already elevated healthcare costs in the US, we view the likelihood of material near-term tariffs on pharma as low," Sheth added. While the headline risk persists, the structural dependence on Indian pharma and the cost sensitivity of the US healthcare system provide a strong case against aggressive tariff action on the sector, Sheth added. Medical Technology Association of India (MTaI) Chairman Pavan Choudary said President Trump's is "troubling and seems economically shortsighted and strategically misguided".

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store